Association between plasma irisin and impaired glucose regulation among Chinese young men: a cross-sectional study

Lina Sun, Dongmei Fan, Yongfang Ma, Xing Wang, Guohui Du, Weinan Zhang, Bowei Liu, Fuzai YinResearch Square 2023 · DOI

Introduction

Diabetes is preceded by a state known as Impaired Glucose Regulation (IGR), or pre-diabetes. While well-studied in older populations, the rise of "early-onset" metabolic disorders in young adults (under 45) presents a significant public health challenge. This study investigates the role of irisin, a muscle-derived hormone (myokine) released during exercise, as a potential biomarker for IGR in young Chinese men. Irisin is known to promote the "browning" of white adipose tissue, enhancing energy expenditure and systemic metabolism.

Methods

This cross-sectional study involved 86 Chinese men aged 18–45 years. Participants were categorized into two groups based on an Oral Glucose Tolerance Test (OGTT):

  1. Normal Glucose Tolerance (NGT): 45 subjects.
  2. Impaired Glucose Regulation (IGR): 41 subjects.

Researchers measured anthropometric data (BMI, waist circumference) and biochemical markers, including fasting plasma glucose (FPG), 2-hour post-load glucose (2hPG), lipids, and serum irisin levels. Insulin resistance was quantified using the HOMA-IR index.

Results

The study found significant metabolic differences between the two groups. Subjects in the IGR group exhibited higher BMI, waist circumference, and insulin resistance (HOMA-IR) compared to the NGT group. Crucially, serum irisin levels were significantly lower in the IGR group (4.43 ± 1.44 µg/mL) than in the NGT group (6.25 ± 1.46 µg/mL).

Clinical characteristics and irisin levels in NGT and IGR groups

Further analysis revealed that the prevalence of "low irisin" was substantially higher in the IGR group (75.6%) compared to the healthy group (26.7%). To determine if irisin was an independent predictor of IGR, the team performed multiple logistic regression.

Multiple logistic regression analysis for predicting IGR

The regression analysis identified both irisin (OR=0.110, P=0.000) and HOMA-IR (OR=5.586, P=0.011) as independent risk factors. An Odds Ratio of 0.110 for irisin indicates that higher levels of this hormone are strongly protective against the development of IGR.

Discussion and Conclusion

The findings suggest that reduced irisin levels are closely associated with impaired glucose homeostasis in young men. While some studies in older or more obese populations have suggested "irisin resistance" (where levels rise to compensate for metabolic failure), this study indicates that in the early stages of glucose impairment among young adults, low irisin is a clear warning sign.

The study is limited by its small sample size and cross-sectional design, which prevents establishing a definitive causal link. However, the results highlight irisin as a promising independent biomarker for early metabolic intervention. Future longitudinal research is needed to confirm if irisin can predict the progression from pre-diabetes to Type 2 Diabetes.

Summary updated

Abstract

<title>Abstract</title> <italic>Objective</italic>: To investigate the association between plasma irisin and impaired glucose regulation (IGR) among Chinese young men. <italic>Materials and Methods</italic>: This cross-sectional study involved 86 Chinese male subjects, aged 18-45 years, who visited the First Hospital of Qinhuangdao (Hebei, China) in 2017 for annual health check-up. Anthropometric measurements, including height, weight and waist circumference (WC) were performed. All patients underwent an oral glucose tolerance test (OGTT) after 8 hours of fasting, and the levels of glucose, insulin, lipids and serum irisin were measured. Participants were categorized into: normal glucose tolerance (NGT) [fasting plasma glucose (FPG)<5.6 mmol/L, and 2-h plasma glucose (2hPG) <7.8 mmol/L after a 75-g OGTT]; IGR[impaired fasting glucose (IFG) ( 5.6mmol/l ≤FPG<7.0 mmol/L, and 2hPG<7.8 mmol/L ) and impaired glucose tolerance (IGT) (FPG<5.6 mmol/L, and 7.8 mmol/l ≤2hPG<11.1 mmol/L]. <italic>Results</italic>: Subjects in the IGR group had higher body mass index (BMI), WC, FPG, 2hPG and homeostasis model assessment of insulin resistance (HOMA-IR), and lower high-density lipoprotein cholesterol(HDL-C) than subjects in the NGT group (<italic>P</italic> &lt; 0.05). The levels of serum irisin (4.43 ± 1.44 vs. 6.25 ± 1.46 µg/mL) were significantly lower in the IGR group (<italic>P</italic>&lt;0.05). The prevalence of obesity (42.2% vs. 65.9%), abdominal obesity (66.7% vs. 85.4%), high levels of triglyceride(22.2% vs. 41.5%), low levels of HDL-C (8.9% vs. 41.5%) and low levels of irisin (26.7% vs. 75.6%) was significantly higher among cases in the IGR group (<italic>P</italic> &lt;0.05). A multiple logistic regression showed that irisin (OR=0.110, <italic>P</italic>= 0.000) and HOMA-IR (OR=5.586, <italic>P</italic> = 0.011) were independent risk factors for predicting IGR. <italic>Conclusions</italic>: Serum irisin levels were reduced in Chinese young men with IGR. Reduced irisin may increase the occurrence of IGR. It suggested that irisin may predict the occurrence of impaired glucose homeostasis and should be examined in future studies.
BibTeX
@inproceedings{sun2023association,
  author = {Lina Sun and Dongmei Fan and Yongfang Ma and Xing Wang and Guohui Du and Weinan Zhang and Bowei Liu and Fuzai Yin},
  title = {{Association between plasma irisin and impaired glucose regulation among Chinese young men: a cross-sectional study}},
  booktitle = {Research Square},
  year = {2023},
  doi = {10.21203/rs.3.rs-2284635/v1},
}
Figure